Update on colchicine, 2017
Anastasia Slobodnick(United States Department of Veterans Affairs), Michael H. Pillinger(VA NY Harbor Healthcare System)
Cited by 247
Related Papers
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial
|The Lancet Respiratory Medicine|2021|271
Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease
|The American Journal of Medicine|2021|122